A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults - Wikidata - awgldk - TriplyDB

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

http://www.wikidata.org/entity/Q33864631

about

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study Pneumococcal vaccine for preventing Streptococcus pneumoniae infection in HIV-infected individuals Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014.The role of vaccination in preventing pneumococcal disease in adults Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program [Vaccination against pneumococci and influenza. How good is the evidence?].Contribution of vaccines to our understanding of pneumococcal disease.High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya.The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.Pneumococcal Vaccination Strategies. An Update and Perspective.Incomplete recovery of pneumococcal CD4 T cell immunity after initiation of antiretroviral therapy in HIV-infected malawian adults.Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.Vaccination in HIV-infected adults.Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.The impact of B-cell perturbations on pneumococcal conjugate vaccine response in HIV-infected adults 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010.Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis.Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.Regulation of naturally acquired mucosal immunity to Streptococcus pneumoniae in healthy Malawian adults and children.Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines Epidemiology of severe acute respiratory illness (SARI) among adults and children aged ≥5 years in a high HIV-prevalence setting, 2009-2012.A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out.Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.Minimum incidence of adult invasive pneumococcal disease in Blantyre, Malawi an urban african setting: a hospital based prospective cohort study Update in pulmonary infections 2010.Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.Community-acquired pneumonia: pneumococcal vaccine.Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination.HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.

P2860

Q21261827-1EF04B80-FCCE-4111-86DE-4487E7488B05 Q24186767-5E09C1DE-5E11-47F1-BB05-49A6989906D0 Q26796420-1DCDFCE3-0E07-4129-A4B4-9A7045B382DF Q26821898-FBDF7CDE-06EF-42BB-B3B9-B9E858CF64DE Q28396749-6F1E625A-D95E-4C7A-96EB-8E39E11EDFD3 Q28742203-CD07B9FB-E462-4365-96D2-6B9FFF129B7D Q30395309-020ECD76-48E1-4373-9719-96949382AAB5 Q30406750-BFD8B190-F13E-4F80-A1A5-1B0661A2B2BA Q33614281-8FEF38A2-131D-4588-8706-19BBBCFD0222 Q33741026-71A2F5D3-11EA-4A79-B31E-20EC55EC19A2 Q33772409-1A2867C2-0081-4E80-9B45-1AEB111B19B3 Q33800556-F20702A7-E22C-4C48-929C-0885D0E123D6 Q33851271-03906DCA-B1F4-45C2-829E-F617FDE0E19F Q33980764-BEE4AAAB-DA0A-4591-81B8-10F2B7C0AD69 Q34043394-C7460A56-CA5F-4C4B-9485-1E287503508E Q34101331-A20CBC41-C451-4B64-8BEA-A0C76B89C0E3 Q34196888-64C6445D-7B46-4F1A-9129-8247126C7B6C Q34311579-50ACE2F2-BBE1-49F2-9504-85859105B905 Q34364783-02EBBAA1-C19C-42AC-9956-A00D46320692 Q34390072-776D2BCD-765E-4DF8-9517-457D2AAC3DCF Q34399272-449EFD97-022D-4774-BE2E-E5906CDC588C Q34406177-D4482B4F-EE6F-49EA-A550-A00D99E6F9FF Q34452479-911CC848-5EC0-462D-BB14-B158DB88D35F Q34531875-AE7F9CB0-0A34-4736-B4A2-801429E98C71 Q34798448-AC066466-1FCB-45D6-8A1C-6625B40142C1 Q34874445-E25E6521-89AB-4A76-BE88-5AD20D5632C0 Q34979620-F67307DD-3D51-4212-B6BB-DCFF327811C1 Q35112120-20AB2213-B40A-429F-BFE7-1DAD7F91792B Q35124323-A9FBB4F3-929F-4207-B194-F1B70BC375C3 Q35134469-ECC73F37-6487-403B-9EEC-95E5A3615CC5 Q35622117-25CC06DA-47D6-4EDE-B3DD-8E148839B8F2 Q35651036-A197A748-E37F-4E61-886D-9907A4E59825 Q35692215-2CBF3520-E7A4-4784-B8F0-08E5FC282C77 Q35753485-D6D6E5B6-A669-494F-A103-67E5ABD63C96 Q35860515-D046BE9F-52B1-466E-A1F2-8E58500983BA Q35907519-FC7526EA-EA3C-4708-BD71-B574F8AEAE9E Q35919614-968C14A0-74A4-4268-99D0-75CB4086BB56 Q35988851-C5CD71B0-04DF-4E08-BB6F-57C1EF87B4A0 Q36009704-C5686D4F-2C6E-4FC5-9E23-F46D1F9118D3 Q36040140-BB03029D-F3FF-407F-A429-3A810906053E

P2860

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

http://www.wikidata.org/entity/Q33864631

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@ast

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@en

type

label

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@ast

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@en

prefLabel

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@ast

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@en

P1433

Q33864631-0488E273-7779-4951-9B3F-05746898AC4F

P1476

Q33864631-9D6C757C-D38F-47BA-A672-92350711693A

P2093

Q33864631-45F55FDE-9A7F-4C0A-877B-7A51C0081A00

Q33864631-5B44DBB1-CE18-4A75-8093-15D2FCD08080

Q33864631-7202AD95-71EF-44E8-BFF0-03E9AC22C8F8

Q33864631-C3EE46D7-D652-483C-BAF7-1A3FA66276A3

Q33864631-E5752D17-4A5E-4AB4-918F-CA486DED43C0

Q33864631-FEF60414-5447-4CAF-9F6F-2F5BB98CEF63

P2860

Q33864631-1E892045-3F44-46A9-AAB6-0F50CDCF8596

Q33864631-221CBE27-8207-4DFF-83B4-79C4AD16D4CE

Q33864631-2E0C7F7C-E201-489A-95C1-CBD0AEB17552

Q33864631-311B9E7D-EFE4-4BA7-A931-EB6AC0BD8875

Q33864631-3E070D40-3191-48EF-882D-DE33921D7F3E

Q33864631-3E8E9EDB-34AA-438A-9096-1762D1DC91F4

Q33864631-3F3485F1-6ED9-422D-AC88-6FE8D7B94A75

Q33864631-41F6AD8A-787F-4F0E-AC08-B52B08056D99

Q33864631-591DE57A-C288-4675-B333-43DB9A5306AD

Q33864631-59A1F262-143C-4243-A244-D157B6816B3C

P304

Q33864631-7C3F532E-D480-4FE8-84A9-9D5BFE7B9EA2

P31

Q33864631-21E3E3FB-C3D8-4B5B-B690-FAC00E1657FE

P356

Q33864631-68DB6E05-C5A0-442B-B60D-871E1DCDC726

P407

Q33864631-69802880-1892-42F9-99D0-06689B8E0280

P433

Q33864631-BA33F1A1-79F5-4E36-864E-D39113AB0B0B

P478

Q33864631-C6178B6D-F8AF-4218-8978-0B2E0BD3A2F8

P50

Q33864631-22549F0C-FB55-4979-A0A5-7CF2FE22FB20

Q33864631-4F69D25A-F98F-443D-BAC8-5758A3235CBB

Q33864631-5E261540-391D-4D70-A1E7-386A4DB860C0

Q33864631-ECEC1442-7CF5-49EE-B328-C8351395ACB6

P577

Q33864631-FCB0D78F-6E8F-4ADE-ACE0-D9D6D11AD187

P698

Q33864631-9F1E7D3C-38B5-408A-B84D-F057FA715778

P932

Q33864631-C88D1B88-DFF4-4E80-8A29-AE5E6063936D

P356

P1433

The New England Journal of Medicine

P1476

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

@en

P2093

Eduard E Zijlstra

http://www.w3.org/2001/XMLSchema#string

Gershom Mwafulirwa

http://www.w3.org/2001/XMLSchema#string

Herbert Longwe

http://www.w3.org/2001/XMLSchema#string

Martin Mwaiponya

http://www.w3.org/2001/XMLSchema#string

Sarah A White

http://www.w3.org/2001/XMLSchema#string

Thandie Mwalukomo

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives.

HIV and pneumococcal disease.

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults.

P304

812-822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0903029

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

362

http://www.w3.org/2001/XMLSchema#string

P50

Malcolm Molyneux

Charles F Gilks

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20200385

http://www.w3.org/2001/XMLSchema#string

P932

2873559

http://www.w3.org/2001/XMLSchema#string